| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/02/1994 | EP0584171A1 Composition and method of treating depigmentation disorders |
| 03/02/1994 | EP0584167A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
| 03/02/1994 | EP0584082A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 03/02/1994 | EP0584066A1 Anti-thrombotic peptide and pseudopeptide derivatives |
| 03/02/1994 | EP0584061A1 Control of milk secretion |
| 03/02/1994 | EP0527787B1 Method of predisposing mammals to accelerated tissue repair |
| 03/02/1994 | EP0509042B1 Pharmaceutical preparation of 1-Octadecyl-2-methyl-glycero-3-phosphocholin for intravenous administration |
| 03/02/1994 | EP0505414B1 Killing of activated lymphocytes |
| 03/02/1994 | EP0494916B1 Feed additive for poultry and poultry feed |
| 03/02/1994 | EP0458929B1 SOLUBILIZATION OF t-PA |
| 03/02/1994 | EP0423244B1 Tumor necrosis factor formulations |
| 03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
| 03/02/1994 | EP0395639B1 Methods and compositions for the treatment of lung conditions |
| 03/02/1994 | EP0391896B1 Enhanced uptake drug delivery system |
| 03/02/1994 | EP0386106B1 Gamma interferon formulation |
| 03/02/1994 | EP0378604B1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
| 03/02/1994 | EP0371998B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/02/1994 | EP0341258B1 Pharmaceutical composition containing interferon for buccal administration |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/02/1994 | CN1083075A Linear peptides |
| 03/02/1994 | CN1083074A Peptide compounds |
| 03/02/1994 | CN1083073A Novel lipophilic oligopeptides with immunomodulating activity |
| 03/02/1994 | CN1083062A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 03/02/1994 | CN1082922A Alleviating stomach ulcers in swine |
| 03/02/1994 | CN1082921A Monomeric platelet-derived growth factor and prevention of stenosis or restenosis |
| 03/02/1994 | CN1082894A Antiviral pharmaceutical compositions for vaginal administration |
| 03/02/1994 | CN1082892A Antiviral agents |
| 03/02/1994 | CN1023901C Novel family of primate hematopoietic growth factors |
| 03/02/1994 | CN1023899C Production method of nutrition liquid |
| 03/02/1994 | CA2104930A1 Nutritive composition and a process for its preparation |
| 03/01/1994 | US5290920 Method of purifying human epidermal growth factor |
| 03/01/1994 | US5290919 Physiological oxygen carrier, artificial blood |
| 03/01/1994 | US5290918 Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation |
| 03/01/1994 | US5290917 Interleukins |
| 03/01/1994 | US5290916 Purified glucanase enzymes |
| 03/01/1994 | US5290764 Stabilization of active plasminogen activator inhibitor-1 |
| 03/01/1994 | US5290763 Ultrafiltration of proteins |
| 03/01/1994 | US5290762 Enzyme inhibitors for protease |
| 03/01/1994 | US5290692 Calcium titanium phosphate glass with sodium oxide and fibrinolytic enzymes for conversion of plasminogen to plasmin bonded to the glass |
| 03/01/1994 | US5290576 Antitumor polypeptide derivatives with iodine |
| 03/01/1994 | US5290571 Undenatured whey protein providing Vitamins B1 and B2 |
| 03/01/1994 | US5290550 Method of treating asthma using IL-8 |
| 03/01/1994 | US5290549 Wound healing agents using masrophage colony stimulating factor for improved lipoprotein cholesterol profile |
| 03/01/1994 | US5290540 Administering, in small particle aerosol form, an anti-inflammatory agent of a corticosteroid, indomethacin, ibuprofen or acetylsalicylic acid and an anti-infectious agent |
| 03/01/1994 | US5290538 Nephro protective infusion solutions |
| 03/01/1994 | CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production |
| 03/01/1994 | CA2104997A1 Bone-related cadherin-like protein and process for its production |
| 03/01/1994 | CA2104995A1 Bone-related sulfatase-like protein and process for its production |
| 03/01/1994 | CA2101599A1 Tri- and tetracyclic compounds |
| 03/01/1994 | CA1327353C Steroidesters from n-(2-halogenethyl)-n-nitroso- carbamoyl-amino-acids and their peptides, and method of producing the same |
| 03/01/1994 | CA1327332C Animal derived cell with antigenic protein introduced therein |
| 03/01/1994 | CA1327329C Recombinant diphtheria toxin fragments |
| 03/01/1994 | CA1327312C Injectable composition for inductive bone repair |
| 03/01/1994 | CA1327311C Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 03/01/1994 | CA1327310C Process for enhancing milk yield in mammals and/or increasing the birth weight of their newborns and postnatal growth |
| 03/01/1994 | CA1327309C Aerosolization of protein therapeutic agent |
| 02/28/1994 | CA2101361A1 Low diol polyalkylene oxide biologically active proteinaceous substances |
| 02/26/1994 | CA2104847A1 Antibiotic stalobacins |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/24/1994 | DE4227892A1 New peptide derivs. of receptor for rhinovirus |
| 02/24/1994 | DE4225925A1 Synthetic HIV-1 protease peptides of amino acids 45-55, 90-99 and 60-70 - either inhibiting or stimulating HIV reverse transcriptase; useful in treatment of HIV-1 or SIV infections |
| 02/23/1994 | EP0584034A2 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/23/1994 | EP0584001A1 Products containing taxol for use in cancer therapy |
| 02/23/1994 | EP0583925A1 Rapamycin for the treatment of Crohn's disease, ulcerative colitis or ulcerative proctitis |
| 02/23/1994 | EP0583917A1 Ampa-binding human GLuR4 receptors |
| 02/23/1994 | EP0583884A1 Megakaryocyte differentiation factor |
| 02/23/1994 | EP0583821A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 02/23/1994 | EP0583799A1 Monoclonal antibodies to ELAM-1 sialoglycoprotein antigen on the surface of activated endothelial cells |
| 02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 02/23/1994 | EP0583726A2 Enteric coated pancreative micropellets |
| 02/23/1994 | EP0583479A1 Remedy for dermatopathy and metallothionein inducer |
| 02/23/1994 | EP0583359A1 Method for treating hypothermia |
| 02/23/1994 | EP0583356A1 A method for treating infectious respiratory diseases |
| 02/23/1994 | EP0583352A1 $i(IN VITRO) METHODS FOR DETERMINING $i(IN VIVO) THROMBOTIC EVENTS |
| 02/23/1994 | EP0583238A1 Modified pollen grains for delivering biologically active substances to plants and animals |
| 02/23/1994 | EP0477274B1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS |
| 02/22/1994 | US5288855 Extracellular form of the human fibroblast growth factor receptor |
| 02/22/1994 | US5288854 Antiinflammatory agents |
| 02/22/1994 | US5288852 Human tumor necrosis factor polypeptides |
| 02/22/1994 | US5288708 Purifying human, animal gastric juice; polypeptide having storng antistress action; treating many diseases |
| 02/22/1994 | US5288707 Thrombin inhibitors |
| 02/22/1994 | US5288706 Medicament for prevention and remedy of diseases of the pancreas and others |
| 02/22/1994 | US5288705 Administering a gonadotrophin and luteinizing hormone releasing hormone embedded in b iopolymers for sustaining release |
| 02/22/1994 | US5288704 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 02/22/1994 | US5288703 Administering syngeristic mixture of animal growth regulator and glutamine |
| 02/22/1994 | US5288639 Purified candidal stress protein or immunogenic epitope or homolog thereof |
| 02/22/1994 | US5288629 Anticoagulants |
| 02/22/1994 | US5288628 Rat osteosarcoma cell line OSR4TR1 |
| 02/22/1994 | US5288622 Human nerve growth factor by recombinant technology |
| 02/22/1994 | US5288615 Methods for preparing proteins of altered structure |
| 02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
| 02/22/1994 | US5288502 Drug delivery |
| 02/22/1994 | US5288490 Anticoagulants having no side effects; immobilizing on the surface of the thrombus to effect lysis |
| 02/22/1994 | US5288489 Fibrinolysis and fibrinogenolysis treatment |
| 02/22/1994 | US5288487 Human monocyte-macrophage-CSF preparations |
| 02/22/1994 | US5288477 Method for prognosticating response to cancer therapy |
| 02/22/1994 | CA2103943A1 Composition and methods for the generation of bone |
| 02/22/1994 | CA1327168C Anti-trichomonas vaginalis monoclonal antibodies |
| 02/22/1994 | CA1327162C Method for prophylactically treating an individual for an autoimmune disease |